Evidence map›Paper›PMID 28692651›Full record

ArticlePloS one2017

Effects of clinical and environmental factors on bronchoalveolar antibody responses to Pneumocystis jirovecii: A prospective cohort study of HIV+ patients.

Robert J Blount, Kieran R Daly, Serena Fong, Emily Chang, Katherine Grieco, Meredith Greene, Stephen Stone, John Balmes, Robert F Miller, Peter D Walzer and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. COPD in People with HIV: Epidemiology, Pathogenesis, Management, and Prevention Strategies.International journal of chronic obstructive pulmonary disease · 2023
    Review
  4. Review
  5. Characteristics and risk factors for Pneumocystis jirovecii pneumonia in patients with idiopathic membranous nephropathy.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2021
    Observational
  6. The Relationship betweenOBM genetics · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Robert J BlountDivision of Pulmonary and Critical Care Medicine, University of California, San Francisco, California, United States of America.ORCID http://orcid.org/0000-0001-6177-7436
Kieran R DalyDivision of Infectious Diseases, University of Cincinnati, Cincinnati, Ohio, United States of America.
Serena FongHIV/AIDS Division, San Francisco General Hospital, University of California, San Francisco, California, United States of America.
Emily ChangHIV/AIDS Division, San Francisco General Hospital, University of California, San Francisco, California, United States of America.
Katherine GriecoHIV/AIDS Division, San Francisco General Hospital, University of California, San Francisco, California, United States of America.
Meredith GreeneHIV/AIDS Division, San Francisco General Hospital, University of California, San Francisco, California, United States of America.
Stephen StoneHIV/AIDS Division, San Francisco General Hospital, University of California, San Francisco, California, United States of America.
John BalmesDivision of Pulmonary and Critical Care Medicine, University of California, San Francisco, California, United States of America.
Robert F MillerResearch Department of Infection and Population Health, Institute of Epidemiology and Healthcare, University College London, London, United Kingdom.
Peter D WalzerDivision of Infectious Diseases, University of Cincinnati, Cincinnati, Ohio, United States of America.
Laurence HuangDivision of Pulmonary and Critical Care Medicine, University of California, San Francisco, California, United States of America.
San Francisco General Hospital · USUnited States Department of Veterans Affairs · USUniversity of California, San Francisco · USLondon School of Hygiene & Tropical Medicine · GB

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MALLORY O JOHNSON · 1988 to 2026
$93.6M
MUTIDISCIPLINARY TRAINING PROGRAM IN LUNG DISEASEST32HL007185 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI David J Erle, LAURENCE HUANG · 1985 to 2026
$24.6M
Inflammation, Aging, Microbes, Obstructive Lung Disease and Diffusion Abnormalities (I AM OLD-DA) Study - Diversity SupplementR01HL128156 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HUANG, LAURENCE, HUNT, PETER W · 2015 to 2024
$7.1M
International HIV-associated Opportunistic Pneumonias (IHOP) StudyR01HL090335 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HUANG, LAURENCE · 2007 to 2011
$4.0M
Patient-Oriented Research and Mentoring in PneumocystisK24HL087713 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HUANG, LAURENCE · 2006 to 2018
$1.8M
Effects of Air Pollution on Childhood Tuberculosis in Viet NamK23ES025807 · NIEHS · UNIVERSITY OF IOWA · PI BLOUNT, ROBERT J · 2015 to 2019
$756k
Effects of Traffic Pollution on Lung Immunity and Pneumonia in Persons with HIVF32ES022582 · NIEHS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BLOUNT, ROBERT J · 2013 to 2014
$134k
NHLBI NIH HHS K24 HL087713NHLBI NIH HHS R01 HL090335NHLBI NIH HHS T32 HL007185NIEHS NIH HHS F32 ES022582NIEHS NIH HHS K23 ES025807
6 · The paper itself

Abstract

backgroundHumoral immunity plays an important role against Pneumocystis jirovecii infection, yet clinical and environmental factors that impact bronchoalveolar antibody responses to P. jirovecii remain uncertain.

methodsFrom October 2008-December 2011 we enrolled consecutive HIV-infected adults admitted to San Francisco General Hospital (SFGH) who underwent bronchoscopy for suspected Pneumocystis pneumonia (PCP). We used local air quality monitoring data to assign ozone, nitrogen dioxide, and fine particulate matter exposures within 14 days prior to hospital admission. We quantified serum and bronchoalveolar lavage fluid (BALF) antibody responses to P. jirovecii major surface glycoprotein (Msg) recombinant constructs using ELISA. We then fit linear regression models to determine whether PCP and ambient air pollutants were associated with bronchoalveolar antibody responses to Msg.

resultsOf 81 HIV-infected patients enrolled, 47 (58%) were diagnosed with current PCP and 9 (11%) had a prior history of PCP. The median CD4+ count was 51 cells/μl (IQR 15-129) and 44% were current smokers. Serum antibody responses to Msg were statistically significantly predictive of BALF antibody responses, with the exception of IgG responses to MsgC8 and MsgC9. Prior PCP was associated with increased BALF IgA responses to Msg and current PCP was associated with decreased IgA responses. For instance, among patients without current PCP, those with prior PCP had a median 73.2 U (IQR 19.2-169) IgA response to MsgC1 compared to a 5.00 U (3.52-12.6) response among those without prior PCP. Additionally, current PCP predicted a 22.5 U (95%CI -39.2, -5.82) lower IgA response to MsgC1. Ambient ozone within the two weeks prior to hospital admission was associated with decreased BALF IgA responses to Msg while nitrogen dioxide was associated with increased IgA responses.

conclusionsPCP and ambient air pollutants were associated with BALF IgA responses to P. jirovecii in HIV-infected patients evaluated for suspected PCP.

Indexed as

EnvironmentAdultAir PollutantsAntibody FormationBronchiBronchoalveolar Lavage FluidEnvironmental ExposureFemaleFungal ProteinsHIV InfectionsHumansImmunoglobulin AMaleMembrane GlycoproteinsMiddle AgedPneumocystis cariniiAir PollutantsFungal ProteinsGPA protein, Pneumocystis carinii sp.Immunoglobulin AMembrane Glycoproteins

Identifiers

PMID28692651
PMCPMC5503245
OpenAlexW2735411375

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.